| |||||||||||||||||||||||||||||||||||||||||||||||||
Schedule:
8:30 AM - 8:40 AM Introduction
Philip Chaikin, Pharm.D., M.D., FCP
Chaikin Associates, LLC
Belle Mead, NJ
8:40 AM - 9:10 AM The Public`s Perspective Merrill Goozner The Center for Science in the Public Interest
9:10 AM- 9:40 AM An Academic Perspective
Kenneth I. Kaitin, Ph.D.
9:40 AM - 10:10 AM A Pharmaceutical and Biotech Industry Perspective
John C. Alexander, M.D.
Daiichi Sankyo Co., Ltd.
Edison, NJ
10:10 AM � 10:30 AM Break 10:30 AM � 11:00 AM A Wall Street Perspective G. Steven Burrill Burrill & Company 11:00 AM - 11:30 AM A Payer`s Perspective Robert S. Epstein, M.D., M.S.
Medco Health Solutions, Inc.
11:30 AM - 12:15 PM Panel Discussion (all speakers)
Moderator:
Philip Chaikin, Pharm.D., M.D., FCP
Chaikin Associates, LLC
Belle Mead, NJ
Vikram Arya, Ph.D., FCP, Senior Clinical Pharmacology Reviewer, Food and Drug Administration, OCP, CDER, Silver Spring, MD Leslie A. Kenna, Ph.D., Senior Statistician/Office of Biostatistics, Food and Drug Administration, CDER, Silver Spring, MD Philip Chaikin, Pharm.D., M.D., FCP, President/Consultant, Chaikin Associates, LLC, Belle Mead, NJ Merrill Goozner, The Center for Science in the Public Interestr , Washington, DC Kenneth I. Kaitin, Ph.D., Director; Professor of Medicine, Tufts Center for the Study of Drug Development; Tufts University School of Medicine, Boston, MA John C. Alexander, M.D., MPH, President (Pharma Development) Global Head of Res & Dev., Daiichi Sankyo Pharma Dev. and Daiichi Sankyo Co., Ltd., Edison, NJ G. Steven Burrill, Burrill & Company, San Francisco, CA Robert S. Epstein, M.D., M.S., Senior VP, Medical & Analytical Affairs & Chief Medical Officer, Medco Health Solutions, Inc., Franklin Lakes, NJ
| |||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
